By forcing the production of the active, altered Becn1F121A or by administering a Beclin-1-operating peptide, Tat-beclin-1 (TB-peptide), Beclin1 is activated in mice, which increased autophagy and greatly enhanced sepsis outcomes, including declines in illness ratings, infection spread, and inflammatory processes. Here, BECN1 is linked to infection.